Valcyte and Pulmicort drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Valcyte (valganciclovir hydrochloride) and Pulmicort (budesonide). Common drug interactions include deformity among females and obliterative bronchiolitis among males.

The phase IV clinical study analyzes what interactions people have when they take Valcyte and Pulmicort. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Valcyte?

Valcyte has active ingredients of valganciclovir hydrochloride. It is often used in cmv - immunocompromised host. eHealthMe is studying from 6,409 Valcyte users. Check the latest studies of Valcyte.

What is Pulmicort?

Pulmicort has active ingredients of budesonide. It is often used in asthma. eHealthMe is studying from 34,980 Pulmicort users. Check the latest studies of Pulmicort.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

15 people who take Valcyte and Pulmicort together, and have interactions are studied.

Valcyte and Pulmicort drug interactions.

What are the common drug interactions of Valcyte and Pulmicort, by gender? *:

female:

Deformity (disfigurement)
General physical health deterioration (weak health status)
Joint stiffness
Joint swelling
Mobility decreased (ability to move is reduced)
Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
Oedema (fluid collection in tissue)
Oedema peripheral (superficial swelling)
Pain
Pain of skin

male:

Obliterative bronchiolitis (bronchiolar inflammation)
Pneumonia
Oxygen saturation decreased
Pneumonitis (inflammation of the walls of the alveoli in the lungs)
Pneumonia fungal
Lymphoedema (localized fluid retention and tissue swelling)
Alveolitis (inflammation in the socket of a tooth)
Asthenia (weakness)
Chest pain
Dyspnoea (difficult or laboured respiration)

What are the common drug interactions of Valcyte and Pulmicort, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

C-reactive protein increased
Cough
Gastroenteritis viral (inflammation of stomach and intestine caused by virus infection)
Haematocrit decreased
Haemoglobin decreased
Hypertension (high blood pressure)
Hyperuricaemia (level of uric acid in the blood that is abnormally high)
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
Pyrexia (fever)
Renal failure (kidney dysfunction)

20-29:

n/a

30-39:

n/a

40-49:

Diarrhoea
Infection
Iron overload
Platelet count decreased
Rash papular (redness with papule)
Urticaria (rash of round, red welts on the skin that itch intensely)

50-59:

Obliterative bronchiolitis (bronchiolar inflammation)
Pneumonia
Pneumonia fungal
Lymphoedema (localized fluid retention and tissue swelling)
Alveolitis (inflammation in the socket of a tooth)
Asthenia (weakness)
Chest pain
Dyspnoea (difficult or laboured respiration)
Lung disorder (lung disease)
Lung infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung)

60+:

Deformity (disfigurement)
General physical health deterioration (weak health status)
Pulmonary fibrosis (formation or development of excess fibrous connective tissue (fibrosis) in the lungs)
Respiratory disorder (respiratory disease)
Scar
Skin discolouration (change of skin colour)
Skin fibrosis (fibrous tissue formation on skin)
Skin hypertrophy (skin cells enlarges)
Skin induration (an abnormally hard spot or area on the skin)
Skin disorder (skin disease)

What are the existing conditions these people have? *

Nuclear Magnetic Resonance Imaging Abdominal: 4 people, 26.67%
Anaemia (lack of blood): 4 people, 26.67%
Acute Kidney Failure: 4 people, 26.67%
Pneumonia Fungal: 3 people, 20.00%
Cytomegalovirus Infection: 2 people, 13.33%
Pain: 1 person, 6.67%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 1 person, 6.67%
Haemolytic Uraemic Syndrome (blood clotting disease caused by e. coli infection, birth control pills, pneumonia, medications, and more): 1 person, 6.67%
Diarrhea: 1 person, 6.67%
Cough: 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Valcyte and Pulmicort?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously